Stayble Therapeutics AB (publ) (STO:STABL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.2130
+0.0230 (12.11%)
Apr 7, 2026, 10:56 AM CET
Market Cap12.23M -55.4%
Revenue (ttm)n/a
Net Income-6.93M
EPS-0.12
Shares Out64.36M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume137,556
Average Volume203,175
Open0.2050
Previous Close0.1900
Day's Range0.1810 - 0.2240
52-Week Range0.1500 - 0.5990
Beta-0.45
RSI52.56
Earnings DateMay 21, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol STABL
Full Company Profile

Financial Performance

Financial Statements